Emcure Pharmaceuticals Founder and CEO Satish Mehta has said that the firm is on track to deliver six crore doses of country's first mRNA COVID-19 vaccine by the end of 2021. "Right now we are in Phase 1. We are very satisfied with the primary outcome of safety," he added. The vaccine is being developed by Emcure's subsidiary Gennova.